Inactive Instrument
Mymetics Corporation Stock Other OTC
Stocks
MYMX
US62856A1025
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 439K 391K 365K 332K 626K 42.25M 630K 4.4M 1.71M 21.55M 1.65M 1.61M 69.28M | P/E 2021 |
-1.86x | P/E 2022 | -1.77x |
|---|---|---|---|---|---|
| Enterprise Value | 72.12M 64.29M 59.93M 54.55M 103M 6.95B 104M 723M 281M 3.54B 271M 265M 11.39B | EV / Sales 2021 |
177x | EV / Sales 2022 | 78x |
| Free-Float |
99.88% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -10.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2012-11-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.24% | +8.79% | - | - | 45 | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -0.37% | -3.88% | +19.75% | +78.35% | 57.39B | |
| +1.63% | +0.98% | +3.83% | +38.21% | 47.64B | |
| +0.50% | +1.32% | +344.62% | +753.25% | 44.29B | |
| +3.05% | -1.58% | +28.78% | +35.46% | 42.5B | |
| +1.00% | +0.22% | +5.17% | +113.80% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +54.06% | 30.97B | |
| +1.56% | +4.53% | +31.34% | +26.92% | 28.53B | |
| +0.76% | -0.89% | -7.44% | -11.43% | 24.34B | |
| Average | +0.07% | -0.59% | +53.86% | +131.42% | 43.39B | |
| Weighted average by Cap. | +1.50% | -0.84% | +58.06% | +140.75% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 430K 383K 357K 325K 613K 41.41M 617K 4.31M 1.68M 21.12M 1.61M 1.58M 67.9M | 1.03M 916K 854K 778K 1.47M 99M 1.48M 10.31M 4.01M 50.48M 3.86M 3.78M 162M |
| Net income | -4.73M -4.22M -3.93M -3.58M -6.74M -455M -6.79M -47.45M -18.46M -232M -17.76M -17.37M -747M | -4.8M -4.28M -3.99M -3.63M -6.85M -463M -6.9M -48.2M -18.75M -236M -18.04M -17.65M -759M |
| Net Debt | 67.1M 59.81M 55.76M 50.75M 95.68M 6.46B 96.3M 673M 262M 3.29B 252M 246M 10.6B | 71.68M 63.9M 59.57M 54.22M 102M 6.9B 103M 719M 280M 3.52B 269M 263M 11.32B |
Employees
-
